Abstract
SUMMARYDelirium is commonly misunderstood in patients with advanced disease. It can present as a hyperactive, hypoactive or fluctuating disorder. Antineoplastic agents and other drugs may cause delirium as can some drug interactions. Potential causes are described. Evaluation instruments that have been used for this symptom are described. Some open research questions are listed. A management algorithm, evidence tables, and drug therapy tables which include drug costs are presented.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Pharmaceutical Care in Pain & Symptom Control
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
